In the race to get type 1 pa­tients off in­sulin, fo­cus turns to cell trans­plants and in­sulin-pro­duc­ing stem cells

When Ser­no­va an­nounced in June that five pa­tients with type 1 di­a­betes with se­vere hy­per­glycemia and a com­plete in­abil­i­ty to pro­duce in­sulin were able to …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.